| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 05/27/2009 | CN101443327A Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof |
| 05/27/2009 | CN101442995A Novel actives against prostate carcinoma |
| 05/27/2009 | CN101439159A Chinese medicinal composition for treating nephropathy and preparation thereof |
| 05/27/2009 | CN101439133A Chinese medicine prescription for quickly treating nephroma and ascites symptoms of broiler chickens |
| 05/27/2009 | CN101439122A Chinese medicine granule containing prepared rehmannia root extract and preparation method thereof |
| 05/27/2009 | CN101439092A Navel paste for treating diarrhea, enuresis, night sweat and spontaneous perspiration, and preparation method thereof |
| 05/27/2009 | CN101439039A Fortifier |
| 05/27/2009 | CN101438914A Method for producing silk quilt for nourishing and protecting kidney |
| 05/27/2009 | CN100491374C 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-KIT inhibitors |
| 05/27/2009 | CN100491368C Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 05/27/2009 | CN100491336C Novel derivatives of 3,3-diphenylpropylamines |
| 05/27/2009 | CN100490884C Chinese medicine for treating urdithiasis and its preparation method |
| 05/27/2009 | CN100490849C Method for preparing houttuynia freeze-dried powder injection |
| 05/27/2009 | CN100490837C Use of Dafabiao extract in pharmacy |
| 05/27/2009 | CN100490834C Preparation method of kidney-tonifying fatigue-eliminating oral liquid containing micropilose antler, safflower seeds etc. |
| 05/27/2009 | CN100490832C Method for preparing kidney-warming face-nourishing liquor containing micron pine pollen, deer placenta powder, glossy privet fruit powder, white fungus, safflower etc. |
| 05/27/2009 | CN100490831C Method for preparing kidney-warming face-nourishing oral liquid containing micron pine pollen, deer placenta powder, glossy privet fruit powder, white fungus, safflower etc. |
| 05/27/2009 | CN100490808C Gliquilone slow-releasing preparation |
| 05/26/2009 | US7538246 Trifluoroacetate blocking of alanine amino group, friedel crafts reaction with methoxybenzene, reduction of carbonyl group, chlorosulphonation and deprotection; claimed tamsulosin intermediates; simplification |
| 05/26/2009 | US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/26/2009 | US7538123 Indole derivative having piperidine ring |
| 05/26/2009 | US7538121 Vanilloid receptor modulators |
| 05/26/2009 | US7538118 6-aminomorphinane derivatives, method for production and use thereof |
| 05/26/2009 | US7538100 17α-alkyl-17β-oxy-estratrienes and intermediate products for their production, use of the 17α-alkyl-17β-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations |
| 05/26/2009 | US7538089 Anti-inflammatory compounds and uses thereof |
| 05/26/2009 | US7537887 Relates to regulation of activity of NET (ERP/SAP-2) protein and to compounds which modify or regulate NET protein activity; methods of screening for agonists or antagonists of NET in order to identify new pro- or anti-angiogenic compounds |
| 05/26/2009 | CA2497857C Novel p-selectin ligand protein |
| 05/26/2009 | CA2474373C N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substituent on the methyl useful as bradykinin antagonists |
| 05/26/2009 | CA2454675C 17alfa, 21-dihydroxypregnene esters as antiandrogenic agents |
| 05/26/2009 | CA2436668C Novel succinate salt of o-desmethyl-venlafaxine |
| 05/26/2009 | CA2334773C Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use |
| 05/26/2009 | CA2230492C Human growth hormone variants |
| 05/22/2009 | WO2009063993A1 Fused pyridine derivative and use thereof |
| 05/22/2009 | WO2009063992A1 Condensed pyridine derivative and use thereof |
| 05/22/2009 | WO2009063991A1 Pyridooxazepine derivative and use thereof |
| 05/22/2009 | WO2009063990A1 Benzazepinone compound |
| 05/22/2009 | WO2009063821A1 Heteroaryloxy quinazoline derivative |
| 05/22/2009 | WO2009062402A1 Quinazolinone derivatives, the preparation methods and uses thereof |
| 05/22/2009 | WO2009062368A1 A process of quality control for a capsule of treatment for prostatitis |
| 05/22/2009 | WO2008034032A3 Beta-lactam cannabinoid receptor modulators |
| 05/22/2009 | CA2705916A1 Benzazepinone compound |
| 05/22/2009 | CA2705370A1 Heteroaryloxy quinazoline derivatives |
| 05/21/2009 | US20090131456 Caspase inhibitors and uses thereof |
| 05/21/2009 | US20090131404 Combinations |
| 05/21/2009 | US20090130715 Antibodies to CD40 |
| 05/21/2009 | US20090130221 Decellularisation of tissue matrices for bladder implantation |
| 05/21/2009 | US20090130066 Augmentation and repair of sphincter defects with cells including muscle cells |
| 05/20/2009 | EP2060630A2 PCA3, PCA3 genes, and methods of use |
| 05/20/2009 | EP2060259A1 Medical compositions for intravesical treatment of bladder cancer |
| 05/20/2009 | EP2059802A2 Methods for designing parp inhibitors and uses thereof |
| 05/20/2009 | EP2059505A2 Muscarinic receptor antagonists |
| 05/20/2009 | EP1565467B1 Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same |
| 05/20/2009 | EP1365760B1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 05/20/2009 | DE102007054653A1 Use of thiourea derivative to degrade advanced glycation end-products, Maillard-products and Amadori products and to prepare medicament to inhibit skin diseases during diabetes and to treat e.g. cataract, arthritis and Alzheimer's disease |
| 05/20/2009 | CN101437828A MGLUR1 antagonists as therapeutic agents |
| 05/20/2009 | CN101434660A Method for extracting Ganoderma lucidum polysaccharide by ultrasonic wave-microwave combination |
| 05/20/2009 | CN101433717A Drugs containing chymase inhibitor and ACE inhibitor as the active ingredients |
| 05/20/2009 | CN101433715A Modified chimeric polypeptides with improved pharmacokinetic properties |
| 05/20/2009 | CN101433705A Pills for tonifying kidney and nourishing qi |
| 05/20/2009 | CN101433661A Oral medicament for Chinese traditional treatment of prostatic hypertrophy |
| 05/20/2009 | CN101433653A Chinese medicinal composition for treating prostatitis and prostatoplasia |
| 05/20/2009 | CN101433589A Oral Chinese medicine decoction for treating primary enuresis symptoms of children |
| 05/20/2009 | CN101433582A Quality control method of capsule for treating prostatitis |
| 05/20/2009 | CN101433549A Calcium oxalate crystallization inhibitor and uses thereof |
| 05/20/2009 | CN101433339A Special sausage with delicious flavour for strongly tonifying kidney and replenishing vital essence |
| 05/20/2009 | CN101433298A Method for preparing waxgourd peel processed article and uses thereof |
| 05/20/2009 | CN100488981C Proaerolysin containing protease activation sequences and its uses |
| 05/20/2009 | CN100488523C Medication of effective part of bee pollen form cole, preparation method and application |
| 05/20/2009 | CN100488511C Compound and use for preparation of the medicament for treatment of benign prostatic hyperplasia and relative diseases |
| 05/20/2009 | CN100488505C Use of Darifenacin and its salts |
| 05/20/2009 | CN100488504C Novel coumarin-amide derivatives and its preparation, its drug composition and use |
| 05/20/2009 | CN100488498C Application of turmeric extract in preparation of medicine for preventing and postponing chronic kidney function failure |
| 05/20/2009 | CN100488372C Method for preparing bone-strengthening kidney-benefiting fatigue-alleviating soybean milk powder with micron deer bone powder, dragon's bone powder, pine pollen and king solomonseal rhizome powder |
| 05/19/2009 | US7534803 Potassium and sodium channel moderators; brain disorders; strokes; multiple sclerosis |
| 05/19/2009 | US7534800 pyrrolo[2,3-b]pyridine derivatives; treatment of neurodegenerative disorders related to apoptosis and/or inflammation; compound prepared by condensation, halogenation, hydrogenation, using silan protected drivatives |
| 05/19/2009 | US7534441 Immunogenic LHRH compositions and methods relating thereto |
| 05/19/2009 | CA2407929C Treatment of congestive heart failure with a composition comprising a diuretic agent and a vasopressin antagonist |
| 05/19/2009 | CA2395969C Novel tetrahydropyridines, method for the preparation thereof and pharmaceutical compositions containing them |
| 05/19/2009 | CA2368059C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 05/19/2009 | CA2230931C 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency |
| 05/14/2009 | WO2009061786A2 Combination therapy comprising angiotensin converting enzyme inhibitors and vasopressin receptor antagonists |
| 05/14/2009 | WO2009061448A2 Methods and compositions for the treatment of proteinuric diseases |
| 05/14/2009 | WO2009061445A2 Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction |
| 05/14/2009 | WO2008073884A3 Treating acute renal failure with soluble thrombomodulin variants |
| 05/14/2009 | US20090124674 Method for treating congestive heart failure |
| 05/14/2009 | US20090124673 Method for treating diabetic nephropathy |
| 05/14/2009 | US20090124645 Novel Pyrimidine-2,4-Diamine Derivatives and their Use as Modulators of Small-Conductance Calcium-Activated Potassium Channels |
| 05/14/2009 | US20090124643 Use of a Cannabinoid CB1 Receptor Antagonist for Preparation of Drugs Useful for the Prevention and Treatment of Benign Prostatic Hypertrophy |
| 05/14/2009 | US20090124623 Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors |
| 05/14/2009 | US20090124541 Method for the recovery and application of novel human defensins as biologically active proteins for the treatment of infections and other diseases |
| 05/14/2009 | US20090123503 Conditioned Cell Culture Medium Compositions and Methods of Use |
| 05/14/2009 | CA2705097A1 Combination therapy comprising angiotensin converting enzyme inhibitors and vasopressin receptor antagonists |
| 05/14/2009 | CA2704663A1 Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction |
| 05/13/2009 | EP2058332A1 Use of CD25 binding molecules in steroid-resistant patients |
| 05/13/2009 | EP2058317A1 Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient |
| 05/13/2009 | EP2058293A1 Lipoxin compounds and their use in treating cell proliferative disorders |
| 05/13/2009 | EP2057992A1 Renal-function-ameliorating agent |
| 05/13/2009 | EP2056866A2 Use of a botulinum toxin for treating a urethral stricture |
| 05/13/2009 | EP2056821A2 Rapamycin and its derivatives for the treatment of liver-associated fibrosing disorders |
| 05/13/2009 | EP2056806A2 Use of certain chemical compounds for the inhibition of the peptidyl-prolyl cis/trans isomerase activity of cyclophilins |